Where does BioCardia Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), BioCardia Inc. ranks #11,941 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does BioCardia Inc. hold?

BioCardia Inc. holds 25 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is BioCardia Inc.'s Innovation Score?

BioCardia Inc. has an Innovation Score of 38.9 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is BioCardia Inc.'s patent grant rate increasing or decreasing?

BioCardia Inc.'s recent grant velocity is -29% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for BioCardia Inc.'s patents?

BioCardia Inc.'s patents average 15.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the BioCardia Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

BioCardia Inc.

Q: What technology areas does BioCardia Inc. focus on?

BioCardia Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 15 patents, ranking #479 of 3,490 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 25 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biocardia ranks #11,941 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 9 technology areas.

#11,941
of 49,997 US assignees by volume: Top 39%
by Innovation Score (38.9/100): 15.1
avg claims per patent: -29%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11941 · US Corporation #11,941 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #11,941/49,997
PHOTO-FINISH Benvenue Medical
CPC-NARROW A61M · 9 areas
INNOV-THIN 38.9/100
CLAIMS-RICH 15.1 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -29% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Benvenue Medical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biocardia’s 38.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (29%) Velocity 8.0 pts (21%) Breadth 10.6 pts (27%) Claim depth 9.1 pts (23%)

Qualcomm Incorporated · highest

85
BioCardia · this assignee

39
Brose Schliessysteme… · near

39
Co2pac · near

39
Soulbrain · near

39
Winnebago Industries · near

39
3D Lighting… · lowest

7

What this shows Biocardia's Innovation Score is 38.9/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biocardia?

Each dot is one of Biocardia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biocardia’s own 15.1 claims/patent is at or below the 19.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Biocardia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biocardia's grants concentrate

BioCardia Inc. is a focused PatentsView assignee: 9 CPC subclasses with 60% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2019. By volume, Biocardia sits between Benvenue Medical, Inc. and Bluefin Payment Systems, LLC.

Biocardia's three-year grant acceleration

BioCardia Inc. shows 6 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Benvenue Medical

25
Bespoke

25
Bicyclerd

25
Bio-pharm Solutio…

25
Blue Current

25
Blue Danube Syste…

25
Blue Origin Manuf…

25
Bluefin Payment S…

25
Biocardia ◀

25

What this shows BioCardia holds 25 patents at rank #11,944, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near BioCardia

By rank, the assignees closest to #11,944 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in BioCardia's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for BioCardia, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), BioCardia ranks #479 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Co2pac Limited 39 Soulbrain Co., Ltd. 39 Brose Schliessysteme GmbH & Co. KG 39 Winnebago Industries, Inc. 39

Biocardia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

BioCardia Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	20.0%
2016	3	12.0%
2017	2	8.0%
2018	3	12.0%
2019	1	4.0%
2020	3	12.0%
2021	1	4.0%
2022	1	4.0%
2023	3	12.0%
2024	2	8.0%
2025partial year	1	4.0%

Which technologies does BioCardia Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 15

A61B - DIAGNOSIS; SURGERY; Identification 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07K - Peptides 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

BioCardia Inc.'s patent record in context - here's where to go next.

BioCardia Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 60% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #11,941 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare BioCardia Inc. against Benvenue Medical, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.